Diagnostic value of neurofilaments in differentiating motor neuron disease from multifocal motor neuropathy

Objective To evaluate the performance of serum neurofilament light chain (NfL) and cerebrospinal fluid (CSF) phosphorylated neurofilament heavy chain (pNfH) as diagnostic biomarkers for the differentiation between motor neuron disease (MND) and multifocal motor neuropathy (MMN).

Methods This retrospective, monocentric study included 16 patients with MMN and 34 incident patients with MND.

A subgroup of lower motor neuron (MN) dominant MND patients ( n  = 24) was analyzed separately.

Serum NfL was measured using Ella automated immunoassay, and CSF pNfH was measured using enzyme-linked immunosorbent assay.

Area under the curve (AUC), optimal cutoff values (Youden’s index), and correlations with demographic characteristics were calculated.

Results Neurofilament concentrations were significantly higher in MND compared to MMN ( p  < 0.001), and serum NfL and CSF pNfH correlated strongly with each other (Spearman’s rho 0.68, p  < 0.001).

Serum NfL (AUC 0.946, sensitivity and specificity 94%) and CSF pNfH (AUC 0.937, sensitivity 90.0%, specificity 100%) performed excellent in differentiating MND from MMN.

Optimal cutoff values were ≥ 44.15 pg/mL (serum NfL) and ≥ 715.5 pg/mL (CSF pNfH), respectively.

Similar results were found when restricting the MND cohort to lower MN dominant patients.

Only one MMN patient had serum NfL above the cutoff.

Two MND patients presented with neurofilament concentrations below the cutoffs, both featuring a slowly progressive disease.

Conclusion Neurofilaments are valuable supportive biomarkers for the differentiation between MND and MMN.

Serum NfL and CSF pNfH perform similarly well and elevated neurofilaments in case of diagnostic uncertainty underpin MND diagnosis.